EIF supports translational med with €25m

The EIF has invested €25m in the Prague-based i&i Biotech Fund I to boost biomedical tech transfer in Austria and Eastern Europe.

Read more

AstraZeneca puts €307m in Irish Alexion plant

Following the $39bn Alexion buy-out completed in July, AstraZeneca plc announced it will invest €307m in the company’s producion site near Dublin.

Read more

Swiss Biotech Day shows great biopharma ambitions

The Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel.

Read more

EuropaBio lobbies for better Orphan Drug rules

EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.

Read more

Cardior bags €64m in Series B Financing

Cardior Pharmaceuticals GmbH is funding a Phase II trial with lead candidate CDR132L against mi-R132-induced heart failure.

Read more

Visus Therapeutics cashes in €20m from LSP

Visus Therapeutics has baged a €20m stock financing to advance development of Brimochol for presbyopia 

Read more